Appointment of Secretarial Auditor
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gujarat Kidney and Super Speciality Ltd reported strong full-year results for FY2025-26. Consolidated revenue surged to Rs 8,201 Lacs from Rs 4,024 Lacs (up ~104% YoY), driven by acquisition of multiple subsidiaries including Raj Patni Hospital, Gujarat Surgical Hospital, Surya Hospital, Harmony Medicare, Parekh's Hospital, and Palit Multi-specialty Hospital. Consolidated PAT grew to Rs 1,681 Lacs from Rs 950 Lacs (up ~77% YoY). However, operating cash flow turned sharply negative at Rs -386 Lacs (vs +Rs 1,361 Lacs prior year) due to large increases in trade receivables, investments, and advance payments for capital assets totalling over Rs 21 crore in investing activities. The company also raised Rs 25,080 Lacs via equity share issuance (net of Rs 3,330 Lacs in share issue expenses). Auditors issued unmodified opinions on both standalone and consolidated results. The Board also deferred CEO appointment and will seek shareholder approval via postal ballot for varying IPO objects.
The company shows strong top-line and bottom-line growth on a consolidated basis, but investors should monitor the negative operating cash flow and large capital deployment, which may pressure near-term liquidity despite the large equity raise.